Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 Registry
(1) Background: This work aims to analyze clinical outcomes according to ethnic groups in patients hospitalized for COVID-19 in Spain. (2) Methods: This nationwide, retrospective, multicenter, observational study analyzed hospitalized patients with confirmed COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry) from 1 March 2020 to 31 December 2021. Clinical outcomes were assessed according to ethnicity (Latin Americans, Sub-Saharan Africans, Asians, North Africans, Europeans). The outcomes were in-hospital mortality (IHM), intensive care unit (ICU) admission, and the use of invasive mechanical ventilation (IMV). Associations between ethnic groups and clinical outcomes adjusted for patient characteristics and baseline Charlson Comorbidity Index values and wave were evaluated using logistic regression. (3) Results: Of 23,953 patients (median age 69.5 years, 42.9% women), 7.0% were Latin American, 1.2% were North African, 0.5% were Asian, 0.5% were Sub-Saharan African, and 89.7% were European. Ethnic minority patients were significantly younger than European patients (median (IQR) age 49.1 (40.5–58.9) to 57.1 (44.1–67.1) vs. 71.5 (59.5–81.4) years, <i<p</i< < 0.001). The unadjusted IHM was higher in European (21.6%) versus North African (11.4%), Asian (10.9%), Latin American (7.1%), and Sub-Saharan African (3.2%) patients. After further adjustment, the IHM was lower in Sub-Saharan African (OR 0.28 (0.10–0.79), <i<p</i< = 0.017) versus European patients, while ICU admission rates were higher in Latin American and North African versus European patients (OR (95%CI) 1.37 (1.17–1.60), <i<p</i< < 0.001) and (OR (95%CI) 1.74 (1.26–2.41), <i<p</i< < 0.001). Moreover, Latin American patients were 39% more likely than European patients to use IMV (OR (95%CI) 1.43 (1.21–1.71), <i<p</i< < 0.001). (4) Conclusion: The adjusted IHM was similar in all groups except for Sub-Saharan Africans, who had lower IHM. Latin American patients were admitted to the ICU and required IMV more often..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Journal of Clinical Medicine - 11(2022), 7, p 1949 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jose-Manuel Ramos-Rincon [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.3390/jcm11071949 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ023935405 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ023935405 | ||
| 003 | DE-627 | ||
| 005 | 20240414120828.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm11071949 |2 doi | |
| 035 | |a (DE-627)DOAJ023935405 | ||
| 035 | |a (DE-599)DOAJ123d30b4cc454b66bf08d651790791aa | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Jose-Manuel Ramos-Rincon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 Registry |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a (1) Background: This work aims to analyze clinical outcomes according to ethnic groups in patients hospitalized for COVID-19 in Spain. (2) Methods: This nationwide, retrospective, multicenter, observational study analyzed hospitalized patients with confirmed COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry) from 1 March 2020 to 31 December 2021. Clinical outcomes were assessed according to ethnicity (Latin Americans, Sub-Saharan Africans, Asians, North Africans, Europeans). The outcomes were in-hospital mortality (IHM), intensive care unit (ICU) admission, and the use of invasive mechanical ventilation (IMV). Associations between ethnic groups and clinical outcomes adjusted for patient characteristics and baseline Charlson Comorbidity Index values and wave were evaluated using logistic regression. (3) Results: Of 23,953 patients (median age 69.5 years, 42.9% women), 7.0% were Latin American, 1.2% were North African, 0.5% were Asian, 0.5% were Sub-Saharan African, and 89.7% were European. Ethnic minority patients were significantly younger than European patients (median (IQR) age 49.1 (40.5–58.9) to 57.1 (44.1–67.1) vs. 71.5 (59.5–81.4) years, <i<p</i< < 0.001). The unadjusted IHM was higher in European (21.6%) versus North African (11.4%), Asian (10.9%), Latin American (7.1%), and Sub-Saharan African (3.2%) patients. After further adjustment, the IHM was lower in Sub-Saharan African (OR 0.28 (0.10–0.79), <i<p</i< = 0.017) versus European patients, while ICU admission rates were higher in Latin American and North African versus European patients (OR (95%CI) 1.37 (1.17–1.60), <i<p</i< < 0.001) and (OR (95%CI) 1.74 (1.26–2.41), <i<p</i< < 0.001). Moreover, Latin American patients were 39% more likely than European patients to use IMV (OR (95%CI) 1.43 (1.21–1.71), <i<p</i< < 0.001). (4) Conclusion: The adjusted IHM was similar in all groups except for Sub-Saharan Africans, who had lower IHM. Latin American patients were admitted to the ICU and required IMV more often. | ||
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a ethnic groups | |
| 650 | 4 | |a minority groups | |
| 650 | 4 | |a migrants | |
| 650 | 4 | |a Spain | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Lidia Cobos-Palacios |e verfasserin |4 aut | |
| 700 | 0 | |a Almudena López-Sampalo |e verfasserin |4 aut | |
| 700 | 0 | |a Michele Ricci |e verfasserin |4 aut | |
| 700 | 0 | |a Manuel Rubio-Rivas |e verfasserin |4 aut | |
| 700 | 0 | |a Francisco Martos-Pérez |e verfasserin |4 aut | |
| 700 | 0 | |a Antonio Lalueza-Blanco |e verfasserin |4 aut | |
| 700 | 0 | |a Sergio Moragón-Ledesma |e verfasserin |4 aut | |
| 700 | 0 | |a Eva-María Fonseca-Aizpuru |e verfasserin |4 aut | |
| 700 | 0 | |a Gema-María García-García |e verfasserin |4 aut | |
| 700 | 0 | |a Jose-Luis Beato-Perez |e verfasserin |4 aut | |
| 700 | 0 | |a Claudia Josa-Laorden |e verfasserin |4 aut | |
| 700 | 0 | |a Francisco Arnalich-Fernández |e verfasserin |4 aut | |
| 700 | 0 | |a Sonia Molinos-Castro |e verfasserin |4 aut | |
| 700 | 0 | |a José-David Torres-Peña |e verfasserin |4 aut | |
| 700 | 0 | |a Arturo Artero |e verfasserin |4 aut | |
| 700 | 0 | |a Juan-Antonio Vargas-Núñez |e verfasserin |4 aut | |
| 700 | 0 | |a Manuel Mendez-Bailon |e verfasserin |4 aut | |
| 700 | 0 | |a Jose Loureiro-Amigo |e verfasserin |4 aut | |
| 700 | 0 | |a María-Soledad Hernández-Garrido |e verfasserin |4 aut | |
| 700 | 0 | |a Jorge Peris-García |e verfasserin |4 aut | |
| 700 | 0 | |a Manuel-Lorenzo López-Reboiro |e verfasserin |4 aut | |
| 700 | 0 | |a Bosco Barón-Franco |e verfasserin |4 aut | |
| 700 | 0 | |a Jose-Manuel Casas-Rojo |e verfasserin |4 aut | |
| 700 | 0 | |a Ricardo Gómez-Huelgas |e verfasserin |4 aut | |
| 700 | 0 | |a on behalf of the SEMI-COVID-19 Network |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of Clinical Medicine |d MDPI AG, 2013 |g 11(2022), 7, p 1949 |w (DE-627)DOAJ000006793 |x 20770383 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:7, p 1949 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/jcm11071949 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/123d30b4cc454b66bf08d651790791aa |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/2077-0383/11/7/1949 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2077-0383 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2022 |e 7, p 1949 | ||